BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31103960)

  • 1. Clinical phenotype in carriers of intermediate alleles in the huntingtin gene.
    Savitt D; Jankovic J
    J Neurol Sci; 2019 Jul; 402():57-61. PubMed ID: 31103960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington's disease: how intermediate are intermediate repeat lengths?
    Squitieri F; Jankovic J
    Mov Disord; 2012 Dec; 27(14):1714-7. PubMed ID: 23008174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Molecular Findings of Intermediate Allele Carriers in the HTT Gene from the Mexican Mestizo Population.
    Ramírez-García MÁ; Dávila-Ortiz de Montellano DJ; Martínez-Ruano L; Ochoa-Morales A; Romero-Hidalgo S; Zenteno JC; Yescas-Gómez P
    Neurodegener Dis; 2022; 22(1):34-42. PubMed ID: 35926480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington's Disease?
    Oosterloo M; Van Belzen MJ; Bijlsma EK; Roos RA
    J Huntingtons Dis; 2015; 4(2):141-8. PubMed ID: 26397895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations of intermediate allele carriers in Huntington disease.
    Cubo E; Ramos-Arroyo MA; Martinez-Horta S; Martínez-Descalls A; Calvo S; Gil-Polo C;
    Neurology; 2016 Aug; 87(6):571-8. PubMed ID: 27402890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTT gene intermediate alleles in neurodegeneration: evidence for association with Alzheimer's disease.
    Menéndez-González M; Clarimón J; Rosas-Allende I; Blázquez M; San Martín ES; García-Fernández C; Lleó A; Dols-Icardo O; Illán-Gala I; Morís G; Ribacoba R; Álvarez V; Martínez C
    Neurobiol Aging; 2019 Apr; 76():215.e9-215.e14. PubMed ID: 30583877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review.
    Apolinário TA; Paiva CL; Agostinho LA
    Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's Disease: Relationship Between Phenotype and Genotype.
    Sun YM; Zhang YB; Wu ZY
    Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.
    Apolinário TA; da Silva IDS; Agostinho LA; Paiva CLA
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1181. PubMed ID: 32067426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HTT CAG repeat expansion among healthy individuals and patients with chorea in Korea.
    Kim R; Seong MW; Oh B; Shin HS; Lee JS; Park S; Jang M; Jeon B; Kim HJ; Lee JY
    Parkinsonism Relat Disord; 2024 Jan; 118():105930. PubMed ID: 37992538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missing the pathological expansion in Huntington disease: de novo c.51C>G variant on the expanded allele causing intrafamilial allele dropout.
    Magri S; Nanetti L; Mongelli A; Rizzo E; Taroni F; Mariotti C; Gellera C
    Am J Med Genet A; 2021 Feb; 185(2):397-400. PubMed ID: 33247537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of intermediary alleles in the HTT gene in Northern Sweden - The Swedish Huntingtin Alleles and Phenotype (SHAPE) study.
    Sundblom J; Niemelä V; Ghazarian M; Strand AS; Bergdahl IA; Jansson JH; Söderberg S; Stattin EL
    Sci Rep; 2020 Jun; 10(1):9853. PubMed ID: 32555394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A series of cases with Huntington-like phenotype and intermediate repeats in HTT.
    Reguera Acuña A; Suárez San Martín E; García Fernández C; Fernández Menéndez S; Blázquez Estrada M; Amorín Díaz M; Menéndez González M; Álvarez Martínez V
    J Neurol Sci; 2021 Jun; 425():117452. PubMed ID: 33892278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.
    da Silva IDS; Apolinário TA; de Andrade Agostinho L; Paiva CLA
    J Mol Neurosci; 2022 May; 72(5):1116-1124. PubMed ID: 35275350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of alleles with an intermediate number of trinucleotide repeats in Parkinson's disease and other neurodegenerative disorders].
    Nikitina MA; Bragina EY; Nazarenko MS; Alifirova VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(7):42-50. PubMed ID: 35904291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of CAA interruption and intergenerational CAG instability in Chinese patients with Huntington's disease.
    Bao YF; Li XY; Dong Y; Wu ZY
    J Mol Med (Berl); 2023 Jul; 101(7):869-876. PubMed ID: 37231148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels.
    Shin A; Shin B; Shin JW; Kim KH; Atwal RS; Hope JM; Gillis T; Leszyk JD; Shaffer SA; Lee R; Kwak S; MacDonald ME; Gusella JF; Seong IS; Lee JM
    Hum Mol Genet; 2017 Apr; 26(7):1258-1267. PubMed ID: 28165127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new mutation for Huntington disease following maternal transmission of an intermediate allele.
    Semaka A; Kay C; Belfroid RD; Bijlsma EK; Losekoot M; van Langen IM; van Maarle MC; Oosterloo M; Hayden MR; van Belzen MJ
    Eur J Med Genet; 2015 Jan; 58(1):28-30. PubMed ID: 25464109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate and Expanded HTT Alleles and the Risk for α-Synucleinopathies.
    Pérez-Oliveira S; Álvarez I; Rosas I; Menendez-González M; Blázquez-Estrada M; Aguilar M; Corte D; Buongiorno M; Molina-Porcel L; Aldecoa I; Martí MJ; Sánchez-Juan P; Infante J; González-Aramburu I; García-González P; Rosende-Roca M; Boada M; Ruiz A; Periñán MT; Macías-García D; Muñoz-Delgado L; Gómez-Garre P; Mir P; Clarimón J; Lleo A; Alcolea D; De la Casa-Fages B; Duarte I; Álvarez V; Pastor P
    Mov Disord; 2022 Sep; 37(9):1841-1849. PubMed ID: 35852957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.